Recombinant F13A1 antibody (AA 46-181)
Quick Overview for Recombinant F13A1 antibody (AA 46-181) (ABIN7875113)
Target
See all F13A1 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 46-181
-
Purpose
- Recombinant F13A1 Antibody / Factor XIIIa
-
Purification
- Protein A affinity chromatography
-
Immunogen
- A recombinant human partial protein (amino acids 46-181) was used as the immunogen for this recombinant F13A1 antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal dilution of the recombinant F13A1 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the recombinant F13A1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
-
Alternative Name
- F13A1
-
Background
- It recognizes a protein of 83 kDa, which is identified as Factor XIIIa. It has been identified in platelets, megakaryocytes, and fibroblast-like mesenchymal or histiocytic cells in the placenta, uterus, and prostate, monocytes and macrophages and dermal dendritic cells. Anti-factor XIIIa has been found to be useful in differentiating between dermatofibroma (almost all cases are positive), dermatofibrosarcoma protuberans (-/+) and desmoplastic malignant melanoma (-). Anti-factor XIIIa positivity is also seen in capillary hemagioblastoma, hemangioendothelioma, hemangiopericytoma, xanthogranuloma, xanthoma, hepatocellular carcinoma, glomus tumor, and meningioma.
-
UniProt
- P00488
Target
-